PER percheron therapeutics limited

Juststocks interview, page-38

  1. 8,307 Posts.
    lightbulb Created with Sketch. 803
    Yes, there does appear to be a reasonable trade here based on cash backing alone. Cash looks to be somewhere between $14 mill and $18 million cash after DecQ is funded. With 1 billion shares on issue the maths is easy . AND management should get some kind of tick for raising $13 million BEFORE the results. AND are their drugs really worth zero now?

    Garner bought $10,500 of stock, why couldn't it be $35k-$50k worth , $10,500 just doesn't pass the pub test for any sign of commitment to the company
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.2¢ 1.3¢ 1.0¢ $277.9K 24.26M

Buyers (Bids)

No. Vol. Price($)
11 2273797 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 5066000 5
View Market Depth
Last trade - 16.14pm 26/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.